April 25, 2016

Hatteras Venture Partners Earns CEO Cancer Gold Standard Accreditation

CARY, N.C.–(BUSINESS WIRE)–The CEO Roundtable on Cancer has accredited Hatteras Venture Partners, an early-stage venture capital investment company in Durham, N.C., with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.

The CEO Roundtable on Cancer, a nonprofit organization of CEOs founded in 2001 by former President George H.W. Bush, developed and administers theGold Standard, a workplace accreditation program which encourages and recognizes the commitment of organizations that take concrete actions to address cancer in their workplaces. Nearly 200 private, nonprofit and government employers in a wide range of occupational categories have earnedGold Standard accreditation, including the National Cancer Institute (NCI) and a number of NCI-designated cancer centers.

To earn Gold Standard accreditation, an employer must establish programs to reduce cancer risk by taking concrete actions in five key areas: establishing policies and programs to reduce cancer risk by prohibiting tobacco use and supporting tobacco cessation efforts; promoting physical activity, healthy nutrition and weight management; providing health insurance options that include detecting cancer at its earliest stages, access to quality care and participation in cancer clinical trials; promoting employee awareness of these initiatives; and supporting the needs of cancer survivors in the workplace.

“Hatteras Venture Partners is leading by example in promoting healthier behavior,” said Robert A. Bradway, chairman and chief executive officer of Amgen and chairman of the CEO Roundtable on Cancer. “I hope their vision and commitment to better health will encourage other employers in N.C. and across all industries and geographies to become Gold Standard accredited.”

“Hatteras is pleased to receive this accreditation,” said Clay Thorp, General Partner. “We followed the incredible work of the CEO Cancer Roundtable for years and believe it has had a profound impact in the oncology field. As investors in a number of health-related therapeutic areas, we believe fostering a health-conscience work environment is vital to support a positive corporate culture.”

In addition to NCI and the Centers for Disease Control and Prevention, 16 NCI-designated cancer centers and more than 100 other hospitals have earned Gold Standard accreditation. CEOs from many industries are keenly aware of the life-improving impact they can have on health and controlling healthcare costs when they address cancer and other chronic diseases. Gold Standard employers include Avis Budget Group, Harvard T.H. Chan School of Public Health, Lowe’s, Amgen, State Farm, Hogan Lovells, Dell, Johnson & Johnson, Novartis, SAS and many Blue Cross affiliates.

About Hatteras Venture Partners

Hatteras Venture Partners is a venture capital firm formed to invest primarily in early stage companies with a focus on biopharmaceuticals, medical devices, diagnostics, healthcare IT and related opportunities in human medicine. The firm has invested across the U.S. but has a special emphasis on companies located in the research-driven regions of North Carolina and the Southeastern United States, which are undercapitalized in comparison to New England and California.

Founded in 2000 and based in Durham, N.C., the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to building successful new biomedical companies. The Hatteras team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With five funds, the firm has approximately $350 million under management.

About The CEO Roundtable on Cancer

The CEO Roundtable on Cancer was founded in 2001, when former President George H.W. Bush challenged a group of executives to “do something bold and venturesome about cancer within your own corporate families.” The CEOs responded by creating and encouraging the widespread adoption of the CEO Cancer Gold Standard™ which calls for organizations to evaluate their health benefits and workplace culture and take extensive, concrete actions in five key areas of health and wellness to address cancer in the workplace. For more information on the CEO Cancer Gold Standard and the free web-based accreditation process, please visitwww.CancerGoldStandard.org.

Hatteras Venture Partners Earns CEO Cancer Gold Standard Accreditation

Tweet this

 Contacts

CEO Roundtable on Cancer Deborah Dion, Communications Manager 919-531-0962 Deborah.Dion@CEORoundtableOnCancer.org


BACK TO NEWS